Infusion of endothelial progenitor cells ameliorates liver injury in mice after haematopoietic stem cell transplantation

Liver International

Volumn 35, Issue 12, 2015, Pages 2611-2620

  Qiao, Jianlin ^a,b   Qi, Kunming ^a   Chu, Peipei ^a,b   Mi, Hongling ^a,b   Yang, Na ^a,b   Yao, Haina ^a,b   Xia, Yuan ^a,b   Li, Zhenyu ^a   Xu, Kailin ^a,b   Zeng, Lingyu ^a,b  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Bone Marrow Stem Cell   (China)

Author keywords

Endothelial progenitor cells; Haematopoietic stem cell transplantation; Liver injury; Liver sinusoidal endothelial cells

Indexed keywords

INTERLEUKIN 6; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL CADHERIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIVER; LIVER CELL; LIVER CELL DAMAGE; LIVER FUNCTION; LIVER INJURY; LIVER STRUCTURE; MOUSE; NONHUMAN; THROMBOCYTE ACTIVATION; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; HEPATIC VENO-OCCLUSIVE DISEASE; LIVER FUNCTION TEST; LIVER REGENERATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; ENDOTHELIAL PROGENITOR CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HEPATOCYTES; INTERLEUKIN-6; LIVER; LIVER FUNCTION TESTS; LIVER REGENERATION; MICE; MICE, INBRED C57BL; P-SELECTIN; PLATELET ACTIVATION; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84983197089     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12849     Document Type: Article

References (38)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-26.
2. Pidala J. Graft-vs-host disease following allogeneic hematopoietic cell transplantation. Cancer Control 2011; 18: 268-76.
3. Ho VT, Linden E, Revta C, et al. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: review and update on the use of defibrotide. Semin Thromb Hemost 2007; 33: 373-88.
4. Senzolo M, Germani G, Cholongitas E, et al. Veno occlusive disease: update on clinical management. World J Gastroenterol 2007; 13: 3918-24.
5. Richardson PG, Ho VT, Giralt S, et al. Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease. Ther Adv Hematol 2012; 3: 253-65.
6. Wadleigh M, Ho V, Momtaz P, et al. Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Curr Opin Hematol 2003; 10: 451-62.
7. Carreras E, Diaz-Beya M, Rosinol L, et al. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant 2011; 17: 1713-20.
8. Cesaro S, Pillon M, Talenti E, et al. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica 2005; 90: 1396-404.
9. Lee SH, Yoo KH, Sung KW, et al. Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Bone Marrow Transplant 2010; 45: 1287-93.
10. Simon M, Hahn T, Ford LA, et al. Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin. Bone Marrow Transplant 2001; 27: 627-33.
11. Cacchione A, LeMaitre A, Couanet DV, et al. Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen. Bone Marrow Transplant 2008; 42: 449-54.
12. Qiao J, Fu J, Fang T, et al. Evaluation of the effects of preconditioning regimens on hepatic veno-occlusive disease in mice after hematopoietic stem cell transplantation. Exp Mol Pathol 2014; 98: 73-8.
13. Cheuk DK. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: prophylaxis and treatment controversies. World J Transplant 2012; 2: 27-34.
14. Coppell JA, Brown SA, Perry DJ. Veno-occlusive disease: cytokines, genetics, and haemostasis. Blood Rev 2003; 17: 63-70.
15. Yoder MC. Human endothelial progenitor cells. Cold Spring Harb Perspect Med 2012; 2: a006692.
16. George AL, Bangalore-Prakash P, Rajoria S, et al. Endothelial progenitor cell biology in disease and tissue regeneration. J Hematol Oncol 2011; 4: 24.
17. Matsumoto K, Yoshitomi H, Rossant J, et al. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001; 294: 559-63.
18. LeCouter J, Moritz DR, Li B, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003; 299: 890-3.
19. Shao H, Tan Y, Eton D, et al. Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels. Stem Cells 2008; 26: 1376-84.
20. Zeng L, Chen C, Song G, et al. Infusion of endothelial progenitor cells accelerates hematopoietic and immune reconstitution, and ameliorates the graft-versus-host disease after hematopoietic stem cell transplantation. Cell Biochem Biophys 2012; 64: 213-22.
21. Harb R, Xie G, Lutzko C, et al. Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury. Gastroenterology 2009; 137: 704-12.
22. Sata M. Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models. Arterioscler Thromb Vasc Biol 2006; 26: 1008-14.
23. Zeng L, Ding S, Yan Z, et al. Irradiation induces homing of donor endothelial progenitor cells in allogeneic hematopoietic stem cell transplantation. Int J Hematol 2012; 95: 189-97.
24. DeLeve LD, McCuskey RS, Wang X, et al. Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 1999; 29: 1779-91.
25. Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med 2005; 56: 79-101.
26. Dong F, Ha XQ. Effect of endothelial progenitor cells in neovascularization and their application in tumor therapy. Chin Med J (Engl) 2010; 123: 2454-60.
27. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-8.
28. Francois S, Mouiseddine M, Allenet-Lepage B, et al. Human mesenchymal stem cells provide protection against radiation-induced liver injury by antioxidative process, vasculature protection, hepatocyte differentiation, and trophic effects. Biomed Res Int 2013; 2013: 151679.
29. Vainshtein JM, Kabarriti R, Mehta KJ, et al. Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2014; 89: 786-803.
30. Agay D, Andriollo-Sanchez M, Claeyssen R, et al. Interleukin-6, TNF-alpha and interleukin-1 beta levels in blood and tissue in severely burned rats. Eur Cytokine Netw 2008; 19: 1-7.
31. Lumadue JA, Lanzkron SM, Kennedy SD, et al. Cytokine induction of platelet activation. Am J Clin Pathol 1996; 106: 795-8.
32. Pignatelli P, De Biase L, Lenti L, et al. Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. Blood 2005; 106: 1992-4.
33. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22: 27-42.
34. Abou-Saleh H, Yacoub D, Theoret JF, et al. Endothelial progenitor cells bind and inhibit platelet function and thrombus formation. Circulation 2009; 120: 2230-9.
35. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008; 28: 223-32.
36. Corada M, Liao F, Lindgren M, et al. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood 2001; 97: 1679-84.
37. Nelson CM, Chen CS. VE-cadherin simultaneously stimulates and inhibits cell proliferation by altering cytoskeletal structure and tension. J Cell Sci 2003; 116: 3571-81.
38. Birdsey GM, Dryden NH, Amsellem V, et al. Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood 2008; 111: 3498-506.